Raymond James & Associates’s Achillion Pharmaceuticals ACHN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-27,216
Closed -$164K 3841
2019
Q4
$164K Sell
27,216
-54,884
-67% -$318K ﹤0.01% 3403
2019
Q3
$296K Buy
82,100
+13,685
+20% +$52.8K ﹤0.01% 3017
2019
Q2
$183K Sell
68,415
-7,000
-9% -$20.7K ﹤0.01% 3296
2019
Q1
$223K Buy
75,415
+3,965
+6% +$9.74K ﹤0.01% 3175
2018
Q4
$114K Buy
71,450
+7,400
+12% +$20.9K ﹤0.01% 3284
2018
Q3
$236K Buy
64,050
+1,000
+2% +$2.98K ﹤0.01% 3195
2018
Q2
$178K Buy
63,050
+200
+0.3% +$681 ﹤0.01% 3294
2018
Q1
$233K Sell
62,850
-5,600
-8% -$18.3K ﹤0.01% 3054
2017
Q4
$197K Sell
68,450
-19,000
-22% -$69K ﹤0.01% 3068
2017
Q3
$393K Sell
87,450
-12,115
-12% -$53.8K ﹤0.01% 2626
2017
Q2
$457K Buy
99,565
+2,100
+2% +$8.44K ﹤0.01% 2479
2017
Q1
$410K Sell
97,465
-5,500
-5% -$22.8K ﹤0.01% 2511
2016
Q4
$425K Sell
102,965
-9,000
-8% -$47.8K ﹤0.01% 2428
2016
Q3
$907K Buy
111,965
+7,784
+7% +$66.2K ﹤0.01% 1947
2016
Q2
$813K Buy
104,181
+5,181
+5% +$44.4K ﹤0.01% 1849
2016
Q1
$764K Sell
99,000
-19,702
-17% -$144K ﹤0.01% 1811
2015
Q4
$1.28M Buy
118,702
+6,552
+6% +$59.6K ﹤0.01% 1501
2015
Q3
$775K Sell
112,150
-8,073
-7% -$65.8K ﹤0.01% 1727
2015
Q2
$1.06M Sell
120,223
-2,477
-2% -$23.4K ﹤0.01% 1703
2015
Q1
$1.21M Buy
122,700
+28,793
+31% +$360K 0.01% 1550
2014
Q4
$1.15M Buy
93,907
+42,207
+82% +$515K 0.01% 1487
2014
Q3
$516K Sell
51,700
-18,700
-27% -$174K ﹤0.01% 1844
2014
Q2
$533K Sell
70,400
-75,600
-52% -$302K ﹤0.01% 1814
2014
Q1
$480K Buy
+146,000
New +$511K ﹤0.01% 1805